Long vs Short Acting Testosterone Treatments: A Look at the Risks. Review uri icon

Overview

abstract

  • Prescriptions for testosterone therapy (TT) to treat testosterone deficiency have increased in recent years. The purpose of this review was to evaluate the risks of several treatment modalities to better counsel patients. Both short-acting and long-acting TT has been shown to restore normal serum testosterone levels and improve symptoms of testosterone deficiency. Short-acting pharmacology mimics normal physiology more closely than long-acting TT but requires multiple doses per day. Long-acting TT has a higher rate of patient adherence but is more likely to create supraphysiologic serum testosterone and pathologic sequelae.

publication date

  • November 28, 2022

Research

keywords

  • Hormone Replacement Therapy
  • Testosterone

Identity

PubMed Central ID

  • PMC9925408

Scopus Document Identifier

  • 85145296586

Digital Object Identifier (DOI)

  • 10.1016/j.urology.2022.11.016

PubMed ID

  • 36455678

Additional Document Info

volume

  • 172